Free Trial

Vanguard Personalized Indexing Management LLC Purchases 4,602 Shares of The Allstate Co. (NYSE:ALL)

Vanguard Personalized Indexing Management LLC boosted its position in The Allstate Co. (NYSE:ALL - Free Report) by 23.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,562 shares of the insurance provider's stock after buying an additional 4,602 shares during the period. Vanguard Personalized Indexing Management LLC's holdings in Allstate were worth $3,438,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Vanguard Group Inc. grew its stake in Allstate by 11.5% during the third quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider's stock worth $3,595,266,000 after purchasing an additional 3,322,673 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Allstate by 3.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 5,926,917 shares of the insurance provider's stock worth $660,318,000 after acquiring an additional 172,250 shares in the last quarter. Diamond Hill Capital Management Inc. raised its holdings in shares of Allstate by 23.0% during the third quarter. Diamond Hill Capital Management Inc. now owns 4,184,211 shares of the insurance provider's stock valued at $466,163,000 after purchasing an additional 782,696 shares during the period. Invesco Ltd. grew its stake in shares of Allstate by 46.6% in the 3rd quarter. Invesco Ltd. now owns 4,121,941 shares of the insurance provider's stock valued at $459,225,000 after buying an additional 1,311,095 shares during the period. Finally, Wellington Management Group LLP increased its position in Allstate by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 3,831,852 shares of the insurance provider's stock valued at $426,907,000 after buying an additional 77,295 shares in the last quarter. Institutional investors own 76.47% of the company's stock.

Allstate Stock Performance


Shares of Allstate stock traded down $2.82 during trading hours on Wednesday, hitting $166.27. 1,482,021 shares of the company's stock traded hands, compared to its average volume of 1,647,382. The stock has a market capitalization of $43.88 billion, a price-to-earnings ratio of 36.77, a PEG ratio of 0.38 and a beta of 0.51. The company has a fifty day simple moving average of $167.74 and a 200-day simple moving average of $153.55. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.36 and a quick ratio of 0.36. The Allstate Co. has a 12-month low of $100.57 and a 12-month high of $177.37.

Allstate (NYSE:ALL - Get Free Report) last released its earnings results on Thursday, May 2nd. The insurance provider reported $5.13 earnings per share for the quarter, beating analysts' consensus estimates of $4.11 by $1.02. Allstate had a net margin of 2.31% and a return on equity of 14.44%. The firm had revenue of $15.26 billion for the quarter, compared to analysts' expectations of $12.76 billion. During the same period in the previous year, the company earned ($1.30) earnings per share. The company's quarterly revenue was up 10.7% on a year-over-year basis. Equities research analysts anticipate that The Allstate Co. will post 15 EPS for the current fiscal year.

Allstate Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, May 31st will be given a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, May 31st. Allstate's dividend payout ratio is currently 81.24%.

Analyst Ratings Changes

Several research analysts have issued reports on the company. UBS Group increased their price target on Allstate from $171.00 to $185.00 and gave the stock a "buy" rating in a report on Monday, February 12th. Evercore ISI boosted their price target on shares of Allstate from $166.00 to $173.00 and gave the company an "in-line" rating in a research note on Thursday, April 11th. BMO Capital Markets upped their price objective on shares of Allstate from $140.00 to $158.00 and gave the stock a "market perform" rating in a report on Friday, January 19th. Morgan Stanley lifted their price objective on shares of Allstate from $187.00 to $190.00 and gave the company an "overweight" rating in a report on Monday, April 15th. Finally, JPMorgan Chase & Co. upped their target price on shares of Allstate from $185.00 to $193.00 and gave the stock an "overweight" rating in a report on Thursday, May 2nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, Allstate has a consensus rating of "Moderate Buy" and an average target price of $174.59.

View Our Latest Analysis on ALL

Insider Activity

In related news, CAO John C. Pintozzi sold 4,000 shares of the business's stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the sale, the chief accounting officer now directly owns 10,736 shares in the company, valued at approximately $1,712,069.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the stock in a transaction on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the sale, the insider now owns 63,731 shares in the company, valued at $10,847,016.20. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CAO John C. Pintozzi sold 4,000 shares of the firm's stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,736 shares of the company's stock, valued at $1,712,069.92. The disclosure for this sale can be found here. Insiders own 1.80% of the company's stock.

Allstate Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

See Also

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL - Free Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Should you invest $1,000 in Allstate right now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: